|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4545 | |
| A61K 31/427 | |||
| A61K 38/21 | |||
| A61K 45/00 | |||
| A61K 9/14 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61P 31/12 |
| (11) | Patento numeris | 3370723 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16862727.1 |
| Europos patento paraiškos padavimo data | 2016-10-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/058937 |
| Data | 2016-10-26 |
| (87) | Numeris | WO 2017/079009 |
| Data | 2017-05-11 |
| (30) | Numeris | Data | Šalis |
| 201562251026 P | 2015-11-04 | US | |
| 201662297740 P | 2016-02-19 | US | |
| 201662321623 P | 2016-04-12 | US |
| (72) |
CORY, David A., US
CHOONG, Ingrid, US
GLENN, Jeffrey S., US
|
| (73) |
Eiger Biopharmaceuticals, Inc.,
2155 Park Boulevard, Palo Alto, CA 94306,
US
|
| (54) | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION |
| TREATMENT OF HEPATITIS DELTA VIRUS INFECTION |